Circ‐0009092 regulates STAT3 modification and reduces CCL2 expression by targeting the miR‐665/NLK signaling axis, which inhibits tumor‐associated macrophage aggregation and slows down the EMT progression of tumor.80 Here, NLK is linked to neoplasm.